IU Simon Cancer Center

About Us

• Mission & Goals
• Milestones
• Resources
• Senior Leaders
• Facilities
• New Construction
• Community Outreach
• Partners
• Facts & Figures
• People Search
• Employment

You are here: HOME > About Us > Facts & Figures

Facts & Figures

• Each year, there are about 38,000 outpatient visits and 4,100 inpatient visits to the IU Simon Cancer Center.
• With its physicians leading about 300 clinical trials for pediatric and adult cancers, IU Simon Cancer Center offers patients diagnostic, treatment, and prevention options not available elsewhere.

• The center has gained international recognition for treatment of breast, genitourinary, thoracic, hematologic and gastrointestinal cancers as well as bone marrow and stem cell transplantation. The IU Simon Cancer Center is home to major cancer treatment successes such as the curative chemotherapy regimen for testis cancer discovered by Lawrence H. Einhorn, MD.
• Physician and basic research scientists teach nearly 2,000 students, residents, and fellows each year at the IU Simon Cancer Center.
• IU Simon Cancer Center established the Indiana Cancer Consortium in collaboration with the American Cancer Society-Great Lakes Division and the Indiana State Department of Health. This statewide network is dedicated to reducing the cancer burden in the state of Indiana through the implementation of a cancer control plan.
• IU Simon Cancer Center received $11.5 million in NCI funding and a total of $32.5 million in other NIH funding for fiscal year 2006.
• More than 200 investigators conduct research in the areas of experimental and development therapeutics, breast cancer, cancer control, as well as hematopoiesis, microenvironment, and immunology.
• The center's work in breast cancer was recognized in 2004 by the Department of Defense with the award of a $10 million grant establishing the IU Center of Excellence for Individualization of Therapy for Breast Cancer.

• The IU Simon Cancer Center’s Translational Research Acceleration Collaboration (ITRAC) is the internal planning and funding process which was implemented to speed the development of new cancer diagnostics and therapies from the laboratory to the bedside.